Jersey Shore NJ
Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement for FluidCrystal Extended Release Formulation of Zilucoplan
CAMBRIDGE, Mass. & LUND, Sweden--(BUSINESS WIRE)--Jul 16, 2019-- |!| Atlantic City
